£500K
The seed round was led by SFC Capital and will fund the continued development of the company technology.
Novai develops artificial intelligence technology for early detection of degenerative eye diseases.
Novai is a biotechnology startup that commercialises an artificial intelligence platform for early detection of eye diseases. The London based firm develops tools to identify cellular level pathology significantly ahead of conventional diagnostic methods.
Francesca Cordeiro
Professor
Francesca brings clinical and academic experience from her roles as a professor and consultant ophthalmologist across Imperial College London and University College London. She also serves as founder and director of Novai.
LinkedInThe seed round was led by SFC Capital and will fund the continued development of the company technology.